- Filed
- May 2, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 84.52M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $5.02M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $4.83M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $20.83M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $17.76M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $40.35M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $44.66M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $63.12M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $67.19M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $105.09M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $112.98M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $390.01M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $393.68M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 87.25M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $13.88M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $11.95M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $421.59M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $415.36M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.08 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.09 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $11.58M |
| Net Income | Q1 2025 · Mar 31, 2024 | $7.29M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $6.97M |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $48.97M |